Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction
选择性抑制造血细胞中的 NF-κB 受体激活剂配体 (RANKL) 可改善实验性心肌梗死后的结果
期刊:Journal of Molecular Medicine-Jmm
影响因子:
doi:10.1007/s00109-018-1641-x
Svetlana Slavic, Olena Andrukhova, Kristopher Ford, Stephan Handschuh, Nejla Latic, Ursula Reichart, Soleman Sasgary, Claudia Bergow, Lorenz C Hofbauer, Paul J Kostenuik, Reinhold G Erben
